Cubist Systematic Strategies, LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 131 filers reported holding XENON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$219,770
+214.1%
5,105
+161.1%
0.00%
Q1 2023$69,969
+902.6%
1,955
+1004.5%
0.00%
Q4 2022$6,979
-99.0%
177
-99.1%
0.00%
-100.0%
Q3 2022$730,000
-54.4%
20,211
-61.6%
0.00%
-60.0%
Q2 2022$1,602,000
-29.2%
52,678
-28.9%
0.01%
-47.4%
Q1 2022$2,263,000
+398.5%
74,039
+409.2%
0.02%
+375.0%
Q4 2021$454,000
+275.2%
14,541
+84.3%
0.00%
+100.0%
Q3 2021$121,000
+255.9%
7,888
+328.5%
0.00%
Q2 2021$34,000
-66.0%
1,841
-67.2%
0.00%
-100.0%
Q1 2021$100,000
+8.7%
5,611
-6.4%
0.00%0.0%
Q4 2020$92,000
+43.8%
5,993
+3.0%
0.00%0.0%
Q3 2020$64,000
-66.8%
5,820
-62.2%
0.00%
-66.7%
Q2 2020$193,000
+4.3%
15,410
-5.5%
0.00%
-40.0%
Q1 2020$185,000
-44.8%
16,307
-36.1%
0.01%
-16.7%
Q4 2019$335,000
+2133.3%
25,515
+1452.0%
0.01%
Q3 2019$15,000
-65.9%
1,644
-63.2%
0.00%
-100.0%
Q2 2019$44,000
-39.7%
4,470
-37.6%
0.00%
-50.0%
Q1 2019$73,000
+78.0%
7,160
+10.4%
0.00%0.0%
Q4 2018$41,000
+583.3%
6,485
+980.8%
0.00%
Q2 2018$6,000
-45.5%
600
-72.7%
0.00%
-100.0%
Q1 2018$11,0002,200
+2100.0%
0.00%
Q4 2017$0
-100.0%
100
-93.1%
0.00%
-100.0%
Q3 2015$12,000
-67.6%
1,440
-54.7%
0.00%
-50.0%
Q2 2015$37,000
+5.7%
3,178
+52.1%
0.00%0.0%
Q1 2015$35,0002,0890.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,754,266$107,388,8317.33%
Altium Capital Management LP 360,600$14,059,7945.74%
Affinity Asset Advisors, LLC 994,227$38,764,9114.47%
First Light Asset Management, LLC 1,306,260$50,931,0774.46%
Nan Fung Group Holdings Ltd 106,680$4,159,4534.44%
Ally Bridge Group (NY) LLC 169,369$6,603,6973.93%
TLS Advisors LLC 32,956$1,2853.22%
BRAIDWELL LP 2,560,573$99,836,7413.13%
Paradigm Biocapital Advisors LP 2,043,280$79,667,4873.05%
BRIDGER MANAGEMENT, LLC 146,800$5,723,7322.94%
View complete list of XENON PHARMACEUTICALS INC shareholders